Lipid F10T5
CAT. NO. DC60840Ionizable lipid studied for CNS mRNA delivery to neurons, microglia and astrocytes through the meningeal lymphatic pathway.
View product →
View larger
Tryptamine-derived ionizable lipid studied for brain-targeted LNP mRNA delivery via intrathecal administration.
Components are supplied separately; this is not a premixed LNP. RNA/cargo, buffer and formulation service are not included.
TD5 is a tryptamine-derived ionizable cationic lipid used to prepare LNPs for mRNA delivery. In the reported formulation, TD5 supported pH-dependent mRNA encapsulation and CNS delivery after intrathecal administration. Reported performance values below remain tied to the stated formulation and study conditions; they should not be compared across methods without reviewing those conditions.
An apparent pKa of 7.30 was reported for the formulated LNP. The value is presented with its measurement context in Product data.
Reduced nonspecific electrostatic interactions while the nanoparticle travels through biological fluid.
Ionizable amines gain charge as pH falls, supporting interaction with endosomal membranes.
Membrane disruption and escape allow encapsulated RNA to reach the cytosol for expression.
| Property | Value |
|---|---|
| CAS No. | 2855180-86-6 |
| Chemical Name | Lipid TD5 |
| Synonyms | Lipid-TD5; TD5; TD-5 |
| SMILES | CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)CCCCCCNC(=O)CCC1=CNC2=CC=CC=C12 |
| Formula | C45H81N3O |
| M.Wt | 680.16 g/mol |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year. In solvent: −80 °C, 6 months; −20 °C, 1 month. Keep sealed and protected from light. |
| Shipping condition | Pure lipid, shipped from Shanghai with ice packs. |
| Publication | Xue Y, et al. Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection. Advanced Materials. 2025;37(27):2417097. DOI: 10.1002/adma.202417097 |
| Component | mol% | Role |
|---|---|---|
| TD5 | 50.0 | Ionizable lipid |
| DOPE | 10.0 | Helper phospholipid |
| Cholesterol | 38.5 | Membrane support |
| DMG-PEG2000 | 1.5 | PEG lipid |
| Total | 100.0 |
The literature-reported TD5 formulation and component molecular weights are pre-filled. Edit any molecular weight or molar ratio when using a different material.
| Component | Molecular weight (g/mol) | Literature molar ratio |
|---|---|---|
| TD5 | ||
| DOPE | ||
| Cholesterol | ||
| DMG-PEG2000 |
| Component | Normalized mol% | Amount (μmol) | Required weight (mg) |
|---|---|---|---|
| Total | 100.000% | — | — |
Calculation aid for research planning. Confirm the molecular weight for the exact PEG-lipid material or batch. The result covers lipid component weights only and does not include RNA, buffer, solvent, process loss or N/P ratio.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final) · C₁V₁ = C₂V₂
Enter the molecular weight above to generate solvent volumes. Formula: volume (mL) = mass (mg) × 1000 ÷ [molecular weight (g/mol) × concentration (mM)].
| Mass | 1 mM | 5 mM | 10 mM |
|---|
Tell us the required size, format and intended formulation. We will confirm price, availability and lead time.
